What changed and when
- May 15, 2026: The outbreak was declared, according to WHO's Nov. 6 report.
- Oct. 23, 2026: The Tumaini Phase 2/3 vaccine trial against Bundibugyo virus launched, with first participants enrolled in Bunia (WHO, Nov. 6).
- Nov. 7, 2026: The count reached 10,920 confirmed cases and 5,323 confirmed deaths (WHO Regional Office for Africa).
- Nov. 11, 2026: The WHO Regional Office for Africa said Ebola is still active in Congo, "with nearly 11 000 confirmed cases and more than 5000 deaths."
- Nov. 15, 2026: The WHO Regional Office for Africa said: "Since the start of the outbreak, more than 11 000 cases and 5400 deaths have been reported."
What the record says comes next
WHO said expert groups recommended adding two more vaccine candidates to the Tumaini trial in Congo: ChAdOx1, developed by the University of Oxford with the Serum Institute of India, and Moderna's mRNA-1469. They will enter the trial following national approvals, and the report gives no date, according to the Nov. 6 report. WHO advises against any restriction of travel to, or trade with, countries experiencing or responding to the outbreak.
Background
Cases have been reported in five countries since the outbreak was declared: the Democratic Republic of the Congo, France, Kenya, Nigeria and Uganda. WHO said the outbreaks in France and Uganda have been controlled since August, and no new cases were reported from Kenya or Nigeria between its Oct. 23 and Nov. 6 reports, according to the Nov. 6 report. WHO described the outbreak as the second documented Bundibugyo virus disease outbreak in Congo, after 2012, and the largest Ebola disease outbreak ever recorded in the country irrespective of virus species. The 2007 and 2012 Bundibugyo outbreaks, in Uganda and in Congo, had case fatality ratios of 30% and 50%.
Kenya's last patient went home on Nov. 11, 2026, which began a 42-day countdown to the end of its outbreak, as covered in Kenya's last Ebola patient goes home.